RxDoctor Payments Data

Sangeeta Hingorani, MD

Pediatric Nephrology · Seattle, WANPI 1306910450

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,430 of the $25,863 with a category attached, or 79.0%. 5 manufacturers reported payments, led by Omeros Corporation at 46.4% of the total. Reporting peaked in 2020 at $12,000 and has fallen 98.7% since, to $161 in 2025. Among pediatric nephrology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,863in general payments, 2019–2025

Across 15 payments — averaging $1724.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Omeros Corporation$12K
  • AstraZeneca$10K
  • Merck$4K
  • Carl Zeiss Meditec USA, Inc.$58
  • Travere Therapeutics, Inc.$4
$31,750in research payments, 2019–2025

Across 1 payment — averaging $31,750 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Omeros Corporation$32K

What the payments were for

  • Consulting fees$20,43079%
  • Speaking & faculty fees$4,16516%
  • Travel & lodging$8963%
  • Food & beverage$3691%
  • Education$40%

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,863 in reported general payments places this provider in the 95th percentile of 21 pediatric nephrology providers in Washington.

See all pediatric nephrology providers in Washington

Medicare billing

Part B allowed, 2024
$5,104
Medicare patients
13
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric nephrology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →